Lygenesis logo
Lygenesis logo

Lygenesis

lygenesis.com
lygenesis.com • HQ: Pittsburgh, United States • Venture - Series Unknown 2023 • 51-200 employees • Founded 2017 • Likely startup • New
HQ: Pittsburgh, United States • Venture - Series Unknown 2023 • 51-200 employees • Founded 2017 • Likely startup • New
Actively hiring
Biotechnology
Regenerative Medicine
Cell & Gene Therapy
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$43.6M
5 rounds on record
Latest round
$17.8M
Venture round · Oct 2023 · 2 yr ago
Team
6
US Form 5500 (plan participants) · Dec 2025 · +100% in a year
The money's age
Long since its last round
35 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2023 $17.8M — SEC Form D
Venture round Oct 2023 $17.8M — SEC Form D
Venture round Dec 2020 $1.9M — SEC Form D
Venture round Oct 2019 $4M — SEC Form D
Venture round May 2018 $2.2M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity LyGenesis Inc. sec
Founders and leadersfrom filings, registers and the company's site
Paulo FontesExecutive OfficerSEC Form D
Eric LegasseExecutive OfficerSEC Form D
Michael HuffordExecutive Officer, DirectorSEC Form D
Eric LagasseExecutive Officer, DirectorSEC Form D
Similar startupsby what they do, their industry and backers
Cellular Origins51-200 employees
Constellation® is an automated cell therapy manufacturing platform that enables scalable, flexible production without therapy redevelopment…
ExthymicVenture round $10.2M · 2 yr ago • Founded 2023 • 51-200 employees • 2 roles
We bring cell therapies to patients through innovative point-of-care manufacturing solutions.
CellusionSeries C $2.8B · 3 yr ago • 1001-5000 employees
Cellusion develops regenerative medicine therapies using induced pluripotent stem (iPS) cells focused on treating corneal endothelial…
Juvena TherapeuticsVenture round $30.5M · 15 mo ago • Founded 2017 • 1001-5000 employees
Juvena Therapeutics is a clinical-stage biotechnology company engineering proteins that human stem cells naturally secrete into…
LEAH Labs11-50 employees
Designer cell therapies for pets first and their people next.
Acorn BiolabsVenture round $3.3M · 7 yr ago • 51-200 employees
Acorn is a personalized regenerative medicine company, helping people preserve their own cells to prepare for the future of cell-based…

Overview

About Us Cell Therapies for Life-Threatening Diseases LyGenesis, Inc. is a clinical-stage cell therapy company that transforms a patient's lymph nodes into bioreactors capable of growing functioning ectopic organs.

People

Paulo Fontes
Executive Officer
SEC Form D
Eric Legasse
Executive Officer
SEC Form D
Michael Hufford
Executive Officer, Director
SEC Form D
Eric Lagasse
Executive Officer, Director
SEC Form D
Gregory Bailey
Director
SEC Form D
James Mellon
Director
SEC Form D
Steve Felstead
Director
SEC Form D
Justin Briggs
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Pittsburgh United States
HQ
50-200 est. staff

Financials

Total raised
$43.6M
Latest round
Venture - Series Unknown
Funding rounds
5
Funding rounds
Round Announced Amount
Venture - Series Unknown 2023 $17.8M Details
Venture - Series Unknown 2023 $17.8M Details
Venture - Series Unknown 2020 $1.9M Details
Venture - Series Unknown 2019 $4M Details
Venture - Series Unknown 2018 $2.2M Details